Genetic variation in thrombin-activatable fibrinolysis inhibitor (TAR) is associated with the risk of splanchnic vein thrombosis

Emile Bruijne, Sarwa Darwish Murad, Moniek de Maat, MWT Tanck, EB Haagsma, B van Hoeks, FR Rosendaal, HLA Janssen, Frank Leebeek

Research output: Contribution to journalArticleAcademicpeer-review

31 Citations (Scopus)
Original languageUndefined/Unknown
Pages (from-to)181-185
Number of pages5
JournalThrombosis and Haemostasis
Issue number2
Publication statusPublished - 2007

Cite this